Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors

There is an unmet need for new therapies in metastatic ovarian cancer and basal-like breast cancer since no curative therapies are currently available. Immunotherapy has shown to be active in several solid tumors, but particularly more in those where a pre-activated immune state does exist. In this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Alcaraz-Sanabria, Ana, Baliu-Piqué, Mariona, Saiz-Ladera, Cristina, Rojas, Katerin, Manzano, Aránzazu, Marquina, Gloria, Casado, Antonio, Cimas, Francisco J., Pérez-Segura, Pedro, Pandiella, Atanasio, Gyorffy, Balázs, Ocana, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965148/
https://ncbi.nlm.nih.gov/pubmed/31998644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01486
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados